Although several tumor characteristics including tumor PD-L1 expression, tumor mutational burden (TMB), and microsatellite instability (MSI) status have been heavily studied, robust tumor-based predictive markers of treatment response remain elusive (4, 8–12). Here, CD274 is linked to neoplasm.